2型糖尿病患者餐后血糖估算模型的构建与验证

目的:构建并验证适合亚洲2型糖尿病(T2DM)患者的餐后血糖(PBG)估算模型。方法:利用糖化血红蛋白(HbA 1c)和指尖空腹血糖(FBG)数据对PBG估算模型进行构建及验证。建模队列来自一项4期、跨国、随机、对照、26周治疗期的临床研究,比较低预混胰岛素和中预混胰岛素作为起始胰岛素在亚洲T2DM患者中的有效性及安全性,患者基线(胰岛素起始治疗前)及26周血糖数据被用于构建PBG估算模型。验证队列来自一项多中心、随机、实用性研究,比较基础胰岛素和中预混胰岛素作为起始胰岛素在接受口服降糖药治疗后血糖仍控制不佳的中国T2DM患者(HbA 1c≥7.5%)中的有效性及安全性,患者基线数据及用药24...

Full description

Saved in:
Bibliographic Details
Published in中华糖尿病杂志 Vol. 13; no. 7; pp. 702 - 707
Main Authors 张雪莲, 冯晨, 马骁, 纪立农, 杨文英
Format Journal Article
LanguageChinese
Published 中日友好医院内分泌科,北京 100029%礼来苏州制药有限公司,上海 200041%北京大学人民医院内分泌科 100044 27.07.2021
Subjects
Online AccessGet full text
ISSN1674-5809
DOI10.3760/cma.j.cn115791-20210224-00102

Cover

Loading…
Abstract 目的:构建并验证适合亚洲2型糖尿病(T2DM)患者的餐后血糖(PBG)估算模型。方法:利用糖化血红蛋白(HbA 1c)和指尖空腹血糖(FBG)数据对PBG估算模型进行构建及验证。建模队列来自一项4期、跨国、随机、对照、26周治疗期的临床研究,比较低预混胰岛素和中预混胰岛素作为起始胰岛素在亚洲T2DM患者中的有效性及安全性,患者基线(胰岛素起始治疗前)及26周血糖数据被用于构建PBG估算模型。验证队列来自一项多中心、随机、实用性研究,比较基础胰岛素和中预混胰岛素作为起始胰岛素在接受口服降糖药治疗后血糖仍控制不佳的中国T2DM患者(HbA 1c≥7.5%)中的有效性及安全性,患者基线数据及用药24周后的血糖数据被用于验证PBG估算模型。基于建模队列数据分布,使用包含两个自变量的线性回归模型构建PBG估算模型。采用由FBG、PBG和HbA 1c构成的数据组,估算每个选定模型估算因子的β回归系数和α截距。选择FBG和HbA 1c作为估算PBG的自变量。使用决定系数R 2评估拟合优度。为进行模型验证,使用该模型估算PBG,并与实测PBG进行比较。计算PBG估算值与实测值间个体差异的平均值及95%置信区间(CI),用于评价该模型估算的准确性,并计算均方根误差(RMSE)。 结果:建模队列研究和验证队列研究分别入组403例和814例T2DM患者。根据散点图中的数据分布,使用包含HbA 1c和FBG两个变量的线性回归模型构建PBG估算模型,PBG(单位mmol/L)=1.5×HbA 1c(单位%)+0.5×FBG(单位mmol/L)-4.1(R 2=0.57)。验证队列PBG估算值为(13.8±3.7)mmol/L,而实测值为(13.7±4.6)mmol/L,患者PBG估算值与实测值个体差异为(0.1±3.4)mmol/L,95%CI为-0.1~0.3, P=0.525。估算模型的RMSE为3.40 mmol/L。 结论:接受口服降糖药或胰岛素治疗的T2DM患者可使用本模型通过HbA 1c和FBG合理可靠地估算PBG。
AbstractList 目的:构建并验证适合亚洲2型糖尿病(T2DM)患者的餐后血糖(PBG)估算模型。方法:利用糖化血红蛋白(HbA 1c)和指尖空腹血糖(FBG)数据对PBG估算模型进行构建及验证。建模队列来自一项4期、跨国、随机、对照、26周治疗期的临床研究,比较低预混胰岛素和中预混胰岛素作为起始胰岛素在亚洲T2DM患者中的有效性及安全性,患者基线(胰岛素起始治疗前)及26周血糖数据被用于构建PBG估算模型。验证队列来自一项多中心、随机、实用性研究,比较基础胰岛素和中预混胰岛素作为起始胰岛素在接受口服降糖药治疗后血糖仍控制不佳的中国T2DM患者(HbA 1c≥7.5%)中的有效性及安全性,患者基线数据及用药24周后的血糖数据被用于验证PBG估算模型。基于建模队列数据分布,使用包含两个自变量的线性回归模型构建PBG估算模型。采用由FBG、PBG和HbA 1c构成的数据组,估算每个选定模型估算因子的β回归系数和α截距。选择FBG和HbA 1c作为估算PBG的自变量。使用决定系数R 2评估拟合优度。为进行模型验证,使用该模型估算PBG,并与实测PBG进行比较。计算PBG估算值与实测值间个体差异的平均值及95%置信区间(CI),用于评价该模型估算的准确性,并计算均方根误差(RMSE)。 结果:建模队列研究和验证队列研究分别入组403例和814例T2DM患者。根据散点图中的数据分布,使用包含HbA 1c和FBG两个变量的线性回归模型构建PBG估算模型,PBG(单位mmol/L)=1.5×HbA 1c(单位%)+0.5×FBG(单位mmol/L)-4.1(R 2=0.57)。验证队列PBG估算值为(13.8±3.7)mmol/L,而实测值为(13.7±4.6)mmol/L,患者PBG估算值与实测值个体差异为(0.1±3.4)mmol/L,95%CI为-0.1~0.3, P=0.525。估算模型的RMSE为3.40 mmol/L。 结论:接受口服降糖药或胰岛素治疗的T2DM患者可使用本模型通过HbA 1c和FBG合理可靠地估算PBG。
Abstract_FL Objective:To develop and validate a model for postprandial blood glucose (PBG) estimation in Asian patients with type 2 diabetes mellitus (T2DM).Methods:The estimation model for PBG was developed and validated based on glycated hemoglobin (HbA 1c) and finger-based fasting blood glucose (FBG). The training cohort was drawn from a phase 4, multinational, randomized, controlled, 26-week trial comparing the efficacy and safety of insulin lispro low-mixture and insulin lispro mid-mixture as an insulin starter in Asian T2DM patients. The glycemic data at baseline (before insulin initiation) and 26 weeks were used for developing the estimation model for PBG. The validation cohort was drawn from a multicenter, randomized, and pragmatic trial comparing the efficacy and safety of basal insulin analog and insulin analog mid-mixture as an insulin starter in Chinese T2DM patients with inadequate glycemic control (HbA 1c ≥7.5%) following oral antihyperglycemic medication (OAM) treatment. The glycemic data at baseline and 24 weeks were used for validating the estimation model. Based on the data distribution of the training cohort, a linear regression model including two variables was used to develop the estimation model. The β regression coefficient of each selected model predictor and α intercept were estimated using the datasets which consisted of FBG, PBG, and HbA 1c. FBG and HbA 1c were selected as independent variables for the estimation for PBG. The goodness of fit was assessed using the decisive factor R 2. For model validation, the PBG value was estimated using this model and compared with the real PBG. The mean of individual differences between estimated PBG and real PBG and the 95% confidence interval (CI) were calculated to evaluate the accuracy of the estimation model. Additionally, the root mean square error (RMSE) was calculated. Results:The clinical trials for the training and validation cohorts enrolled, respectively, 403 and 814 patients with T2DM. Based on data distribution through scatter plot, a linear regression model including two variables, HbA 1c and FBG, was used for developing PBG estimation model: PBG (Unit: mmol/L) = 1.5×HbA 1c (Unit: %)+0.5×FBG (Unit: mmol/L)-4.1 (R 2=0.57). In the validation cohort, the estimated PBG was (13.8±3.7) mmol/L and the real PBG was (13.7±4.6) mmol/L with the individual differences between the estimated PBG and real PBG being (0.1±3.4) mmol/L, 95%CI being -0.1 to 0.3, and P being 0.525. The RMSE for the estimation model was 3.40 mmol/L. Conclusion:Patients with T2DM treated with OAM or insulin could estimate their PBG with HbA 1c and FBG using this estimation model with reasonable accuracy.
Author 纪立农
杨文英
冯晨
马骁
张雪莲
AuthorAffiliation 中日友好医院内分泌科,北京 100029%礼来苏州制药有限公司,上海 200041%北京大学人民医院内分泌科 100044
AuthorAffiliation_xml – name: 中日友好医院内分泌科,北京 100029%礼来苏州制药有限公司,上海 200041%北京大学人民医院内分泌科 100044
Author_FL Ma Xiao
Zhang Xuelian
Feng Chen
Ji Linong
Yang Wenying
Author_FL_xml – sequence: 1
  fullname: Zhang Xuelian
– sequence: 2
  fullname: Feng Chen
– sequence: 3
  fullname: Ma Xiao
– sequence: 4
  fullname: Ji Linong
– sequence: 5
  fullname: Yang Wenying
Author_xml – sequence: 1
  fullname: 张雪莲
– sequence: 2
  fullname: 冯晨
– sequence: 3
  fullname: 马骁
– sequence: 4
  fullname: 纪立农
– sequence: 5
  fullname: 杨文英
BookMark eNotT7tKA0EUnSKCMeYztJt478zOzkxhIcEXBGy0DrMvNegEXEWwipJUSkhlwCIQtBALDdiICv5M9pG_cH1Uh_PgHM4CKdm2DQlZQqhx6cKKf2xqrZpvEYXUSBkwBMYcClBgiZTRlQ4VCvQ8qcbxoQeIGnThlskqS0bX2ettMvnKhr306j7v9GYPg2TQz8edQp9-TrLnYfo4_ondddNRN_l4n771Z083-cvlIpmLzFEcVv-xQvY21nfrW7Sxs7ldX2vQGAE1ZcYo1-hAFMwJIsCAG1SuJxVwodFoiRyN0L7rISgT-lxFACKUDBGDiPMKWf7rPTc2Mna_2WqfndhisXlxcGq938MSQPNvaLNiKA
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3760/cma.j.cn115791-20210224-00102
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
DocumentTitle_FL An estimation model for postprandial blood glucose levels in patients with type 2 diabetes mellitus
EndPage 707
ExternalDocumentID zhtnb202107009
GroupedDBID 2B.
4A8
92I
93N
ALMA_UNASSIGNED_HOLDINGS
CDYEO
PSX
TCJ
ID FETCH-LOGICAL-s1019-2aa86a9d51014df01d3a186b7803591a97131a59c6b108aec38f005e72111df33
ISSN 1674-5809
IngestDate Thu May 29 03:54:41 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords 糖尿病,2型
餐后血糖
Diabetes mellitus, type 2
Estimation model
估算模型
Postprandial blood glucose
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-s1019-2aa86a9d51014df01d3a186b7803591a97131a59c6b108aec38f005e72111df33
PageCount 6
ParticipantIDs wanfang_journals_zhtnb202107009
PublicationCentury 2000
PublicationDate 2021-07-27
PublicationDateYYYYMMDD 2021-07-27
PublicationDate_xml – month: 07
  year: 2021
  text: 2021-07-27
  day: 27
PublicationDecade 2020
PublicationTitle 中华糖尿病杂志
PublicationTitle_FL Chinese Journal of Diabetes Mellitus
PublicationYear 2021
Publisher 中日友好医院内分泌科,北京 100029%礼来苏州制药有限公司,上海 200041%北京大学人民医院内分泌科 100044
Publisher_xml – name: 中日友好医院内分泌科,北京 100029%礼来苏州制药有限公司,上海 200041%北京大学人民医院内分泌科 100044
SSID ssib011909001
ssib048413644
ssib007286532
ssib003003870
ssib051368295
Score 2.2462955
Snippet 目的:构建并验证适合亚洲2型糖尿病(T2DM)患者的餐后血糖(PBG)估算模型。方法:利用糖化血红蛋白(HbA...
SourceID wanfang
SourceType Aggregation Database
StartPage 702
Title 2型糖尿病患者餐后血糖估算模型的构建与验证
URI https://d.wanfangdata.com.cn/periodical/zhtnb202107009
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Na9RAFA-lBfEiiorf9uAcUzOTyXwcPGSyCUXQUwu9lXxsLIIrtNtLT1Xak1LqxYKHQtGDeNCCF1HBf6bbj__C9ybZTapStbCE5M2b937vvd15L9mZiePc0b5QQqvS5VBbuLyU1NUqFW4Jya3IvRQqdFw7_OChmJ7l9-eCubHxV61ZS8v9bCpf-eO6ktNEFWgQV1wl-x-RHQkFApxDfOEIEYbjP8WYkTggOibKkFgS4xMtkGI8YhKkaElUQGJBFCOhT2KF8xqQoknIifZsd6DE2BRSbG3kcGIiFAWUMEZRICe0bG2lOiSKYxNSuNVuiAltd2Ulgy7giayKhFRvThmWwzVb2MGOqmP5TzREd9AWbEqIHqVQS4hI6KE2bVBhbJUb1mZRAhGgFMCkmha4gk80hEqbFommoDTwgbEWWyk6aj8sYRSfwlZ7D9ivd8sqgdDDwPZLagFwaSqDI3QWQgbFrJatKmaF59AdfIG-AyHgBXB9goYixXbHqHCLESi-ja6Hf6UwTVhge9koVo5DGAoxABJ0mMSYVbqMsE2doX9Aha6BVd8SQBVGtRVgWgOjCnNooVqZQxi4OItTC-N3qAECA4vwBJSKuslUcjxr6en803JCteNnnXEFjBGB8vSxlOy3hh7Zyq_SY61STVYvTP61CsB5XvDTzZ-kU4-n8h5uJ6Wpy6qnG9y12yg25c9oUurKQr-XWS5plwRPMLjzhFw_EZqOSVpJEWd8NElO4truZnE2hQpbD-dywDVXUCaKpoYO4Eox-zaokelnHFLDvnsiaLuwsFemvUetGnjmvHOuvnmdDKuR6IIztrJw0bnHBtsvDj6_Huz-ONha33_-9nB1_ejd5mBz43BnFeh733cPPm7tv99Btjdr-9trg29f975sHH14efjp2SVnNolnomm3fimLuwTZW7ssTZVIdYG5nBelRws_pUpkUuFmoDTVkvo0DXQuMuqptJv7qoRM38UnTbQoff-yM9572utecSZTyTKmc14ELODdvNBCS7zBKLmXUZoXV53btbnz9aC7NH88SNf-ynHdOduMAzec8f7icvcm3Eb0s1t1YH8CRlzFhg
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2%E5%9E%8B%E7%B3%96%E5%B0%BF%E7%97%85%E6%82%A3%E8%80%85%E9%A4%90%E5%90%8E%E8%A1%80%E7%B3%96%E4%BC%B0%E7%AE%97%E6%A8%A1%E5%9E%8B%E7%9A%84%E6%9E%84%E5%BB%BA%E4%B8%8E%E9%AA%8C%E8%AF%81&rft.jtitle=%E4%B8%AD%E5%8D%8E%E7%B3%96%E5%B0%BF%E7%97%85%E6%9D%82%E5%BF%97&rft.au=%E5%BC%A0%E9%9B%AA%E8%8E%B2&rft.au=%E5%86%AF%E6%99%A8&rft.au=%E9%A9%AC%E9%AA%81&rft.au=%E7%BA%AA%E7%AB%8B%E5%86%9C&rft.date=2021-07-27&rft.pub=%E4%B8%AD%E6%97%A5%E5%8F%8B%E5%A5%BD%E5%8C%BB%E9%99%A2%E5%86%85%E5%88%86%E6%B3%8C%E7%A7%91%EF%BC%8C%E5%8C%97%E4%BA%AC%E3%80%80100029%25%E7%A4%BC%E6%9D%A5%E8%8B%8F%E5%B7%9E%E5%88%B6%E8%8D%AF%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8%EF%BC%8C%E4%B8%8A%E6%B5%B7%E3%80%80200041%25%E5%8C%97%E4%BA%AC%E5%A4%A7%E5%AD%A6%E4%BA%BA%E6%B0%91%E5%8C%BB%E9%99%A2%E5%86%85%E5%88%86%E6%B3%8C%E7%A7%91%E3%80%80100044&rft.issn=1674-5809&rft.volume=13&rft.issue=7&rft.spage=702&rft.epage=707&rft_id=info:doi/10.3760%2Fcma.j.cn115791-20210224-00102&rft.externalDocID=zhtnb202107009
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhtnb%2Fzhtnb.jpg